Importantly, EPHA3 is highly expressed on the tumor-initiating cell population in glioma, which potentially maintains tumor cells in a less differentiated state by modulating mitogen-activated protein kinase signaling. The gene discussed is WNK2; the disease is central nervous system cancer.